Skip to main content

RXCopilot Trust Centre

Trust is governed through evidence, responsibility and visible limits.

Review how intended use, governance, validation, clinical safety, responsible AI, privacy, security, transparency and Professional Responsibility are separated and connected.

Eight-pillar model

Trust domains with visible scope and status.

Public labels describe governance functions. They do not imply that named individuals or formally staffed authorities have been appointed.

Intended Use

Define purpose, authorised users and boundaries.

Current scope
Public platform purpose and use boundaries
Status
controlled-preview
Governance function
Product and clinical governance

Clinical Governance

Assign review, approval, release and change responsibility.

Current scope
Clinical oversight, change control and accountability
Status
controlled-preview
Governance function
Clinical governance

Evidence and Validation

Connect claims with evidence, evaluation and limitations.

Current scope
Public claims, evidence scope, limitations and validation status
Status
controlled-preview
Governance function
Evidence and validation

Clinical Safety

Identify hazards, controls and escalation pathways.

Current scope
Public safety principles and escalation boundaries
Status
controlled-preview
Governance function
Clinical safety

Privacy

Use patient information only for defined and authorised purposes.

Current scope
Public privacy principles and request-data handling
Status
controlled-preview
Governance function
Privacy governance

Security

Protect information, infrastructure and operational integrity.

Current scope
Public security principles; no certification claim
Status
controlled-preview
Governance function
Security governance

Transparency

Make status, limitations and uncertainty visible.

Current scope
Capability, claim, limitation and jurisdiction status
Status
controlled-preview
Governance function
Transparency and publication governance

Professional Responsibility

Keep clinical authority with qualified healthcare professionals.

Current scope
Professional review, judgement and accountability boundaries
Status
controlled-preview
Governance function
Clinical governance

Intended use

Purpose and boundaries come before capability.

Public information must distinguish the intended purpose, authorised users, setting, workflow, configuration, jurisdiction and exclusions.

  • Use statement

    What the capability is designed to support.

  • Authorised context

    Who, where and under what configuration it may be used.

  • Boundary statement

    What it does not do and what still requires professional review.

Review capability status

Professional Responsibility

Clinical authority remains with qualified healthcare professionals.

System support and professional accountability are deliberately separated.

  • RXCopilot may support

    Organisation, drafting, contextualisation and visibility of unresolved matters within approved scope.

  • Healthcare professionals remain responsible

    Verification, Clinical Judgement, decisions, patient communication, documentation approval and care.

Read the complete statement

Governance lifecycle

Control continues after publication.

A governed artefact moves through defined states with traceable decisions.

  1. Define

    Establish purpose, scope and accountable governance function.

  2. Review

    Assess clinical, legal, technical and communication implications.

  3. Approve

    Bind decisions to exact wording, evidence, version and jurisdiction.

  4. Release

    Publish only within authorised scope.

  5. Monitor

    Track evidence, incidents, expiry, drift and change.

  6. Restrict or supersede

    Withdraw safely while preserving history.

Claims framework

Material claims fail closed.

A claim is publishable only when its exact wording, evidence, method, limitations, scope, dates and required approvals are current.

  • Exact wording

    Approval applies to the words actually published.

  • Evidence

    Evidence is linked to the claim and defined scope.

  • Methodology

    The way evidence was generated is available for review.

  • Limitations

    Known boundaries remain visible.

  • Approval and expiry

    Required roles, effective dates and review dates are valid.

  • Fail-closed rendering

    Unapproved, restricted, suspended or expired claims are withheld or replaced by a controlled fallback.

Evidence and Validation

Validation grid

Evidence will be published only when it can be scoped honestly.

The Evidence and Validation page remains intentionally sparse until approved records exist. No results are invented to complete the design.

  • Capability and version

    What exact implementation was evaluated?

  • Cohort and setting

    Who and what environment were represented?

  • Method and measures

    How was performance assessed?

  • Material findings

    What worked, failed or remained uncertain?

  • Limitations

    Where should results not be generalised?

  • Corrective action and retest

    What changed and what evidence followed?

Open Evidence and Validation

Clinical safety

Safety is an active control system.

Hazards, controls, escalation, monitoring and residual risk remain connected to intended use and release.

  • Hazard identification

    Identify plausible ways the system could contribute to harm.

  • Preventive controls

    Constrain inputs, outputs, authority and workflow.

  • Detection

    Make uncertainty, failure and material anomalies visible.

  • Escalation

    Route safety-significant matters to the relevant governance function.

  • Incident response

    Restrict, communicate, investigate, correct and review.

  • Residual risk

    State what controls do not eliminate.

Responsible AI

AI-supported functions remain governed clinical components.

Responsible use requires more than a general AI principle statement.

  • Human authority

    No transfer of Professional Judgement or accountability.

  • Purpose limitation

    Use is constrained to an authorised clinical and organisational context.

  • Transparency

    System-generated, inferred and uncertain content remains identifiable.

  • Evaluation

    Performance and limitations are assessed for defined versions and populations.

  • Equity

    Relevant subgroup and access risks require review.

  • Contestability

    Professionals can inspect, correct, reject and escalate.

Privacy and security

Related disciplines with distinct questions.

No certification or compliance status should be inferred unless expressly published.

  • Privacy

    Is information used for a defined, authorised and transparent purpose with appropriate minimisation, rights and retention?

  • Security

    Are identity, access, data, infrastructure and operational integrity protected, monitored and recoverable?

Regulatory status

Regulatory status is jurisdiction-, product- and version-specific.

Architecture, a controlled preview, validation activity or availability in one environment does not establish approval elsewhere.

  • Current public statement

    No certification or regulatory approval is asserted on this page.

  • Source of truth

    Any future status must identify the jurisdiction, product or capability, version, scope, effective date and supporting record.

Assurance distinctions

Different assurance domains must not be collapsed into one badge.

Each domain answers a different question.

  • Technical verification

    Does implementation conform to technical requirements?

  • Clinical validation

    Does evidence support a defined clinical use?

  • Clinical safety

    Are hazards and controls governed?

  • Privacy and security

    Are information rights and protective controls addressed?

  • Regulatory

    What formal status applies?

  • Operational

    Can the service be monitored, supported and recovered?

Limitations register

Known limits should be easier to find than marketing conclusions.

Public limitations are versioned, scoped and updated when evidence or status changes.

  • Availability

    Capabilities may be unavailable or restricted by version, setting, organisation or jurisdiction.

  • Evidence

    Architecture and implementation do not establish clinical effectiveness.

  • Information quality

    Incomplete, outdated or conflicting input can affect support.

  • Professional review

    Material outputs require verification and acceptance.

  • Integration

    External-system behaviour and data quality create separate dependencies.

  • Localisation

    Local adaptation is not regulatory approval or market availability.

Documents and notices

Current public records and status routes.

Documents remain sparse where approved evidence does not yet exist.

  • Capability Status

    Approved public availability by controlled scope.

  • Evidence and Validation

    Claim-linked methods, findings and limitations when approved.

  • Professional Responsibility

    The system and professional authority boundary.

  • Privacy

    Public privacy information and request handling.

  • Accessibility

    Accessibility commitments and known status.

  • Current notices

    Publication restrictions, corrections or status changes when required.

Publication governance

What appears publicly is itself governed.

Content, claims, capability status, media and metadata move together through review and rollback controls.

  1. Author

    Create versioned content with source references.

  2. Review

    Check clinical, legal, evidence, safety and accessibility implications.

  3. Approve

    Record exact scope and effective dates.

  4. Publish

    Release the atomic approved version.

  5. Monitor

    Watch expiry, incident and status signals.

  6. Correct

    Restrict or roll back coherently and preserve history.

Questions and boundaries

Frequently asked questions

Does the Trust Centre certify RXCopilot?

No. It explains governance scope and status. Certification or approval is stated only when an applicable current record expressly supports it.

Why is Evidence and Validation sparse?

Claims without active evidence and approval records are withheld. The page will grow as scoped evidence is generated and approved.

Who owns each trust area?

The public site names governance functions, not appointed individuals or staffed authorities. Operational assignments remain subject to formal appointment.

Does a controlled preview mean clinically approved?

No. Preview status does not establish clinical effectiveness, regulatory approval or general availability.

How are misleading or expired claims handled?

They are suppressed or replaced with an approved fallback, and material incidents can trigger restriction, correction and controlled restoration.

Is professional review always required?

Material clinical outputs remain within the Professional Responsibility boundary and require the applicable professional review before approved use.

How are privacy and security different?

Privacy governs appropriate and transparent use of information; security protects information, systems and operations. Both are required.

Where can I see current capability availability?

Use the controlled Capability Status page; do not infer availability from architecture, prototypes or internal implementation.

Trust information is subject to the claims, capability, jurisdiction and publication registers. Architecture and documentation alone do not establish certification, approval, safety or effectiveness.

Trust should be inspectable.

Review the current status records or discuss assurance, governance and organisational requirements with RXCopilot.

Essential storage remembers this choice. It does not track browsing behaviour.

Privacy-respecting website analytics

Understand governed navigation, content use and errors without clinical or identifying content.

Current choice: not selected — optional analytics off.

Read the cookie notice · Read the privacy notice

Trust Centre | RXCopilot